Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NE › Omaha › NPI 1700072261
Lab

Vaccination Services of America, INC.

Vaccination Services of America, INC. was paid $181K by Medicaid between Sep 2020 and Aug 2022, across 6 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 35% of everything it billed.

33Billing provider infoVACCINATION SERVICES OF AMERICA, INC.
OMAHA, NE 68127
33aNPI1700072261assigned 09/19/2007
28Total paid$181K
24GClaims5,683
24DCodes billed6
24AFirst – last monthSep 2020 – Aug 2022
Compared with peers

Next to other Clinical Medical Laboratory providers in Nebraska

Rank by total paid#8 of 19
Median peer was paid$18K
This provider vs. median9.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$25K$50K$75K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2020673$21K
20212,022$53K
20222,988$107K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 35% 1,088 963 $63K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 20% 3,043 2,473 $36K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 17% 380 324 $32K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 14% 279 254 $25K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 13% 783 681 $23K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.5% 110 89 $3K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKOHLL, ALAN (PRESIDENT/OWNER)